Highlights
KLSE: DKSH (5908)       DKSH HOLDINGS MALAYSIA BHD MAIN : Consumer
Last Price Today's Change   Day's Range   Trading Volume
3.50   0.00 (0.00%)  3.48 - 3.55  98,700
Analyze this stock with MQ Trader system

Financials


Market Cap: 552 Million

Market Cap 552 Million
NOSH 158 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 27-May-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 27-May-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  30-Sep-2020 [#3]

Latest Quarter: 30-Sep-2020 [#3]
Announcement Date 25-Nov-2020
Next Quarter: 31-Dec-2020
Est. Ann. Date: 19-Feb-2021
Est. Ann. Due Date: 01-Mar-2021
QoQ | YoY   74.16%  |    26.97%

Annual (Unaudited) ( EPS: 24.79, P/E: 14.12 )

Revenue | NP to SH 6,455,088  |  39,085
RPS | P/RPS 4,094.36 Cent  |  0.09
EPS | P/E | EY 24.79 Cent  |  14.12  |  7.08%
DPS | DY | Payout % 10.00 Cent  |  2.86%  |  40.34%
NAPS | P/NAPS 3.93  |  0.89
YoY   -12.39%
NP Margin | ROE 0.61%  |  6.30%
F.Y. | Ann. Date 31-Dec-2019  |  19-Feb-2020

T4Q Result ( EPS: 31.01, P/E: 11.29 )

Revenue | NP to SH 6,415,779  |  48,892
RPS | P/RPS 4,069.43 Cent  |  0.09
EPS | P/E | EY 31.01 Cent  |  11.29  |  8.86%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 4.13  |  0.85
QoQ | YoY   6.30%  |    51.21%
NP Margin | ROE 0.76%  |  7.50%
F.Y. | Ann. Date 30-Sep-2020  |  25-Nov-2020

Annualized Result ( EPS: 26.71, P/E: 13.11 )

Revenue | NP to SH 6,409,606  |  42,102
RPS | P/RPS 4,065.51 Cent  |  0.09
EPS | P/E | EY 26.71 Cent  |  13.11  |  7.63%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   17.38%  |    45.05%
NP Margin | ROE 0.66%  |  6.46%
F.Y. | Ann. Date 30-Sep-2020  |  25-Nov-2020


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2020 25-Nov-2020 30-Sep-2020 3 6,409,606 67,222 42,102 42,102 - 651,821 - % 0.66% 6.46% 157,658 4,065.51 4,065.51 26.71 26.71 0.00 0.00 4.1344 4.13   17.38%   45.05% 30-Sep-2020 2.90 0.07 10.86 0.70 9.21% 0.00% 25-Nov-2020 3.50 0.09 13.11 0.85 7.63% 0.00%
31-Dec-2020 26-Aug-2020 30-Jun-2020 2 6,343,120 64,140 35,870 35,870 - 638,199 - % 0.57% 5.62% 157,658 4,023.34 4,023.34 22.76 22.76 0.00 0.00 4.0480 4.05   -11.23%   62.66% 30-Jun-2020 2.49 0.06 10.94 0.62 9.14% 0.00% 26-Aug-2020 3.24 0.08 14.24 0.80 7.02% 0.00%
31-Dec-2020 28-May-2020 31-Mar-2020 1 6,893,884 74,196 40,408 40,408 - 630,348 - % 0.59% 6.41% 157,658 4,372.68 4,372.68 25.64 25.64 0.00 0.00 3.9982 4.00   3.38%   1,734.63% 31-Mar-2020 1.97 0.05 7.69 0.49 13.01% 0.00% 28-May-2020 2.68 0.06 10.46 0.67 9.56% 0.00%
31-Dec-2019 19-Feb-2020 31-Dec-2019 4 6,455,088 60,996 39,085 39,085 15,765 620,289 40.34% 0.61% 6.30% 157,658 4,094.36 4,094.36 24.79 24.79 10.00 10.00 3.9344 3.93   34.65%   -12.39% 31-Dec-2019 2.62 0.06 10.57 0.67 9.46% 3.82% 19-Feb-2020 2.60 0.06 10.49 0.66 9.53% 3.85%
31-Dec-2019 29-Oct-2019 30-Sep-2019 3 6,462,018 48,548 29,026 29,026 21,021 602,979 72.42% 0.45% 4.81% 157,658 4,098.76 4,098.76 18.41 18.41 13.33 13.33 3.8246 3.82   31.63%   -36.07% 30-Sep-2019 2.54 0.06 13.80 0.66 7.25% 5.25% 29-Oct-2019 2.50 0.06 13.58 0.65 7.36% 5.33%
31-Dec-2019 30-Aug-2019 30-Jun-2019 2 6,272,408 37,300 22,052 22,052 31,531 592,242 142.99% 0.35% 3.72% 157,658 3,978.49 3,978.49 13.98 13.98 20.00 20.00 3.7565 3.76   992.07%   -55.65% 28-Jun-2019 2.74 0.07 19.59 0.73 5.10% 7.30% 30-Aug-2019 2.51 0.06 17.94 0.67 5.57% 7.97%
31-Dec-2019 31-May-2019 31-Mar-2019 1 6,250,700 3,324 -2,472 -2,472 - 596,341 - % -0.04% -0.41% 157,658 3,964.72 3,964.72 -1.56 -1.56 0.00 0.00 3.7825 3.78   -105.54%   -105.72% 29-Mar-2019 2.34 0.06 -149.24 0.62 -0.67% 0.00% 31-May-2019 2.58 0.07 -164.55 0.68 -0.61% 0.00%
31-Dec-2018 25-Feb-2019 31-Dec-2018 4 6,011,839 60,583 44,615 44,615 15,765 597,003 35.34% 0.74% 7.47% 157,658 3,813.21 3,813.21 28.30 28.30 10.00 10.00 3.7867 3.79   -1.73%   -14.19% 31-Dec-2018 2.30 0.06 8.13 0.61 12.30% 4.35% 25-Feb-2019 2.72 0.07 9.61 0.72 10.40% 3.68%
31-Dec-2018 08-Nov-2018 30-Sep-2018 3 5,885,502 61,793 45,402 45,402 21,021 586,440 46.30% 0.77% 7.74% 157,658 3,733.08 3,733.08 28.80 28.80 13.33 13.33 3.7197 3.72   -8.69%   -6.43% 28-Sep-2018 3.35 0.09 11.63 0.90 8.60% 3.98% 08-Nov-2018 3.05 0.08 10.59 0.82 9.44% 4.37%
31-Dec-2018 08-Aug-2018 30-Jun-2018 2 5,796,274 67,136 49,722 49,722 31,531 577,233 63.42% 0.86% 8.61% 157,658 3,676.48 3,676.48 31.54 31.54 20.00 20.00 3.6613 3.66   15.01%   -5.84% 29-Jun-2018 3.38 0.09 10.72 0.92 9.33% 5.92% 08-Aug-2018 3.90 0.11 12.37 1.07 8.09% 5.13%
31-Dec-2018 22-May-2018 31-Mar-2018 1 5,822,692 57,920 43,232 43,232 - 578,936 - % 0.74% 7.47% 157,658 3,693.24 3,693.24 27.44 27.44 0.00 0.00 3.6721 3.67   -16.85%   7.59% 30-Mar-2018 3.85 0.10 14.04 1.05 7.12% 0.00% 22-May-2018 4.30 0.12 15.68 1.17 6.38% 0.00%
31-Dec-2017 26-Feb-2018 31-Dec-2017 4 5,510,354 70,721 51,994 51,994 14,977 568,073 28.81% 0.94% 9.15% 157,658 3,495.13 3,495.13 32.98 32.98 9.50 9.50 3.6032 3.60   7.16%   3.03% 29-Dec-2017 3.98 0.11 12.07 1.10 8.29% 2.39% 26-Feb-2018 3.90 0.11 11.83 1.08 8.46% 2.44%
31-Dec-2017 31-Oct-2017 30-Sep-2017 3 5,511,133 66,360 48,521 48,521 19,970 552,496 41.16% 0.88% 8.78% 157,658 3,495.62 3,495.62 30.77 30.77 12.67 12.67 3.5044 3.50   -8.11%   -1.91% 29-Sep-2017 4.70 0.13 15.27 1.34 6.55% 2.70% 31-Oct-2017 4.68 0.13 15.21 1.34 6.58% 2.71%
31-Dec-2017 09-Aug-2017 30-Jun-2017 2 5,526,730 71,958 52,806 52,806 29,955 469,505 56.73% 0.96% 11.25% 157,658 3,505.52 3,505.52 33.50 33.50 19.00 19.00 2.9780 2.98   31.41%   -16.68% 30-Jun-2017 4.90 0.14 14.63 1.65 6.84% 3.88% 09-Aug-2017 5.00 0.14 14.93 1.68 6.70% 3.80%
31-Dec-2017 24-May-2017 31-Mar-2017 1 5,478,672 54,036 40,184 40,184 - 468,323 - % 0.73% 8.58% 157,658 3,475.03 3,475.03 25.48 25.48 0.00 0.00 2.9705 2.97   -20.38%   -10.86% 31-Mar-2017 4.69 0.13 18.40 1.58 5.43% 0.00% 24-May-2017 5.21 0.15 20.44 1.75 4.89% 0.00%
31-Dec-2016 21-Feb-2017 31-Dec-2016 4 5,271,047 68,897 50,467 50,467 14,977 531,086 29.68% 0.96% 9.50% 157,658 3,343.34 3,343.34 32.01 32.01 9.50 9.50 3.3686 3.37   2.02%   37.00% 30-Dec-2016 4.47 0.13 13.96 1.33 7.16% 2.13% 21-Feb-2017 5.31 0.16 16.59 1.58 6.03% 1.79%
31-Dec-2016 22-Nov-2016 30-Sep-2016 3 5,259,500 67,649 49,468 49,468 19,970 517,701 40.37% 0.94% 9.56% 157,658 3,336.02 3,336.02 31.37 31.37 12.67 12.67 3.2837 3.28   -21.94%   38.67% 30-Sep-2016 5.55 0.17 17.69 1.69 5.65% 2.28% 22-Nov-2016 6.15 0.18 19.60 1.87 5.10% 2.06%
31-Dec-2016 23-Aug-2016 30-Jun-2016 2 5,375,374 86,094 63,374 63,374 29,955 512,278 47.27% 1.18% 12.37% 157,658 3,409.51 3,409.51 40.20 40.20 19.00 19.00 3.2493 3.25   40.58%   42.46% 30-Jun-2016 3.68 0.11 9.15 1.13 10.92% 5.16% 23-Aug-2016 4.60 0.13 11.44 1.42 8.74% 4.13%
31-Dec-2016 24-May-2016 31-Mar-2016 1 5,331,188 62,716 45,080 45,080 - 506,823 - % 0.85% 8.89% 157,658 3,381.49 3,381.49 28.60 28.60 0.00 0.00 3.2147 3.21   22.38%   -7.81% 31-Mar-2016 4.00 0.12 13.99 1.24 7.15% 0.00% 24-May-2016 3.80 0.11 13.29 1.18 7.52% 0.00%
31-Dec-2015 23-Feb-2016 31-Dec-2015 4 5,572,186 51,009 36,836 36,836 14,977 495,582 40.66% 0.66% 7.43% 157,658 3,534.35 3,534.35 23.36 23.36 9.50 9.50 3.1434 3.14   3.26%   -38.52% 31-Dec-2015 4.00 0.11 17.12 1.27 5.84% 2.38% 23-Feb-2016 4.00 0.11 17.12 1.27 5.84% 2.38%
31-Dec-2015 24-Nov-2015 30-Sep-2015 3 5,621,708 49,613 35,673 35,673 19,970 485,508 55.98% 0.63% 7.35% 157,658 3,565.76 3,565.76 22.63 22.63 12.67 12.67 3.0795 3.08   -19.81%   -37.24% 30-Sep-2015 4.10 0.11 18.12 1.33 5.52% 3.09% 24-Nov-2015 4.54 0.13 20.06 1.47 4.98% 2.79%
31-Dec-2015 25-Aug-2015 30-Jun-2015 2 5,582,276 61,196 44,484 44,484 - 480,935 - % 0.80% 9.25% 157,658 3,540.75 3,540.75 28.22 28.22 0.00 0.00 3.0505 3.05   -9.03%   -20.44% 30-Jun-2015 5.00 0.14 17.72 1.64 5.64% 0.00% 25-Aug-2015 4.00 0.11 14.18 1.31 7.05% 0.00%
31-Dec-2015 11-May-2015 31-Mar-2015 1 5,676,528 67,244 48,900 48,900 - 485,870 - % 0.86% 10.06% 157,658 3,600.53 3,600.53 31.00 31.00 0.00 0.00 3.0818 3.08   -18.38%   -9.44% 31-Mar-2015 5.32 0.15 17.15 1.73 5.83% 0.00% 11-May-2015 5.31 0.15 17.12 1.72 5.84% 0.00%
31-Dec-2014 26-Feb-2015 31-Dec-2014 4 5,339,481 80,415 59,911 59,911 35,473 473,636 59.21% 1.12% 12.65% 157,658 3,386.75 3,386.75 38.00 38.00 22.50 22.50 3.0042 3.00   5.39%   -65.73% 31-Dec-2014 5.38 0.16 14.16 1.79 7.06% 4.18% 26-Feb-2015 5.90 0.17 15.53 1.96 6.44% 3.81%
31-Dec-2014 13-Nov-2014 30-Sep-2014 3 5,278,914 76,276 56,845 56,845 47,297 456,341 83.20% 1.08% 12.46% 157,658 3,348.33 3,348.33 36.05 36.05 30.00 30.00 2.8945 2.89   1.67%   -8.93% 30-Sep-2014 6.47 0.19 17.94 2.24 5.57% 4.64% 13-Nov-2014 6.54 0.20 18.14 2.26 5.51% 4.59%
31-Dec-2014 26-Aug-2014 30-Jun-2014 2 5,296,054 75,374 55,912 55,912 70,946 441,663 126.89% 1.06% 12.66% 157,658 3,359.20 3,359.20 35.46 35.46 45.00 45.00 2.8014 2.80   3.55%   -5.36% 30-Jun-2014 8.28 0.25 23.35 2.96 4.28% 5.43% 26-Aug-2014 6.56 0.20 18.50 2.34 5.41% 6.86%
31-Dec-2014 20-May-2014 31-Mar-2014 1 5,148,052 71,736 53,996 53,996 - 462,679 - % 1.05% 11.67% 157,658 3,265.33 3,265.33 34.24 34.24 0.00 0.00 2.9347 2.93   -69.11%   15.33% 31-Mar-2014 9.00 0.28 26.28 3.07 3.81% 0.00% 20-May-2014 7.81 0.24 22.80 2.66 4.39% 0.00%
31-Dec-2013 26-Feb-2014 31-Dec-2013 4 5,085,623 190,445 178,342 174,828 18,130 449,168 10.37% 3.51% 38.92% 157,652 3,225.84 3,225.73 110.89 110.89 11.50 11.50 2.8491 2.85   180.08%   124.82% 31-Dec-2013 6.45 0.20 5.82 2.26 17.19% 1.78% 26-Feb-2014 7.00 0.22 6.31 2.46 15.84% 1.64%
31-Dec-2013 21-Nov-2013 30-Sep-2013 3 5,078,077 78,722 66,701 62,421 24,178 319,528 38.73% 1.31% 19.54% 157,682 3,220.44 3,220.94 39.59 39.59 15.33 15.34 2.0264 2.03   5.66%   28.43% 30-Sep-2013 5.90 0.18 14.90 2.91 6.71% 2.60% 21-Nov-2013 6.42 0.20 16.22 3.17 6.17% 2.39%
31-Dec-2013 28-Aug-2013 30-Jun-2013 2 5,041,376 74,746 63,434 59,080 36,255 302,130 61.37% 1.26% 19.55% 157,630 3,198.22 3,197.66 37.48 37.47 23.00 23.00 1.9167 1.92   26.19%   19.90% 28-Jun-2013 5.03 0.16 13.42 2.62 7.45% 4.57% 28-Aug-2013 5.07 0.16 13.53 2.65 7.39% 4.54%
31-Dec-2013 22-May-2013 31-Mar-2013 1 4,974,160 58,628 51,068 46,820 - 302,657 - % 1.03% 15.47% 157,749 3,153.21 3,155.03 29.68 29.70 0.00 0.00 1.9186 1.92   -39.79%   6.85% 29-Mar-2013 3.25 0.10 10.95 1.69 9.13% 0.00% 22-May-2013 5.44 0.17 18.33 2.84 5.46% 0.00%
31-Dec-2012 28-Feb-2013 31-Dec-2012 4 4,724,726 94,014 81,810 77,762 11,037 290,844 14.19% 1.73% 26.74% 157,673 2,996.52 2,996.82 49.32 49.32 7.00 7.00 1.8446 1.84   60.00%   76.34% 31-Dec-2012 2.25 0.08 4.56 1.22 21.92% 3.11% 28-Feb-2013 2.87 0.10 5.82 1.56 17.18% 2.44%
31-Dec-2012 23-Nov-2012 30-Sep-2012 3 4,715,290 73,912 52,453 48,602 14,714 254,491 30.28% 1.11% 19.10% 157,658 2,990.83 2,990.83 30.83 30.83 9.33 9.33 1.6142 1.61   -1.36%   10.77% 28-Sep-2012 2.14 0.07 6.94 1.33 14.41% 4.36% 23-Nov-2012 2.17 0.07 7.04 1.34 14.21% 4.30%
31-Dec-2012 24-Aug-2012 30-Jun-2012 2 4,680,062 76,132 52,886 49,274 22,072 242,683 44.79% 1.13% 20.30% 157,658 2,968.49 2,968.49 31.26 31.26 14.00 14.00 1.5393 1.54   12.45%   9.80% 29-Jun-2012 2.12 0.07 6.78 1.38 14.74% 6.60% 24-Aug-2012 2.05 0.07 6.56 1.33 15.25% 6.83%
31-Dec-2012 25-May-2012 31-Mar-2012 1 4,494,808 65,844 46,868 43,820 - 240,034 - % 1.04% 18.26% 157,658 2,850.98 2,850.98 27.80 27.80 0.00 0.00 1.5225 1.52   -0.63%   3.20% 30-Mar-2012 1.95 0.07 7.02 1.28 14.25% 0.00% 25-May-2012 1.91 0.07 6.87 1.25 14.55% 0.00%
31-Dec-2011 24-Feb-2012 31-Dec-2011 4 4,260,749 67,687 48,872 44,098 7,094 229,139 16.09% 1.15% 19.25% 157,646 2,702.72 2,702.53 27.97 27.97 4.50 4.50 1.4535 1.45   0.51%   57.70% 30-Dec-2011 1.56 0.06 5.58 1.07 17.93% 2.88% 24-Feb-2012 1.86 0.07 6.65 1.28 15.04% 2.42%
31-Dec-2011 29-Nov-2011 30-Sep-2011 3 4,290,616 67,257 48,904 43,876 9,459 210,934 21.56% 1.14% 20.80% 157,660 2,721.42 2,721.47 27.83 27.83 6.00 6.00 1.3379 1.34   -2.23%   87.85% 30-Sep-2011 1.46 0.05 5.25 1.09 19.06% 4.11% 29-Nov-2011 2.06 0.08 7.40 1.54 13.51% 2.91%
31-Dec-2011 26-Aug-2011 30-Jun-2011 2 4,252,852 68,308 49,500 44,876 14,189 200,409 31.62% 1.16% 22.39% 157,665 2,697.38 2,697.52 28.46 28.46 9.00 9.00 1.2711 1.27   5.69%   212.59% 30-Jun-2011 1.47 0.05 5.16 1.16 19.36% 6.12% 26-Aug-2011 1.46 0.05 5.13 1.15 19.50% 6.16%
31-Dec-2011 19-May-2011 31-Mar-2011 1 4,285,248 63,748 46,596 42,460 - 195,728 - % 1.09% 21.69% 157,769 2,716.14 2,718.06 26.92 26.93 0.00 0.00 1.2406 1.24   51.84%   330.11% 31-Mar-2011 0.95 0.03 3.53 0.77 28.33% 0.00% 19-May-2011 1.25 0.05 4.64 1.01 21.53% 0.00%
31-Dec-2010 25-Feb-2011 31-Dec-2010 4 3,867,610 45,556 32,034 27,963 5,440 184,934 19.45% 0.83% 15.12% 157,686 2,452.73 2,453.16 17.72 17.74 3.45 3.45 1.1728 1.17   19.72%   31.37% 30-Dec-2010 1.05 0.04 5.92 0.90 16.89% 3.29% 25-Feb-2011 0.81 0.03 4.57 0.69 21.89% 4.26%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Trade this stock and receive a FREE I3investor T-shirt after 5 trades. Find out more.
  6 people like this.
 
cbkia4896 Let it sleep la, wake up with a bang when necessary
21/10/2020 2:02 PM
investorking2020 Sad enough, DKSH is not a sleeping beauty. So, do not expect it to wake up and give you a nice surprise. The reason it is sleeping is that is not very well managed, wasting a lot money on acquisitions to plug top-line gaps while profitability is deteriorating. That is why DKSH is not attracting any attention among investors.
23/10/2020 2:12 PM
sapurakencana investorking,,think about digi,why Norway they keen to buy RM2.85 from our major shareholder when there is Technology crisis during 2020,see what happen after 7 year RM23 & RM55 on 2012 before bonus issue.
23/10/2020 11:19 PM
cbkia4896 Sighhh. Here we go again....
https://www.thestar.com.my/news/world/2020/11/09/pfizer-biontech-say-their-covid-19-vaccine-is-more-than-90-effective
09/11/2020 8:32 PM
Benlee88888 Omg, tmr limit up?
All stock up as well?
09/11/2020 9:01 PM
Wilson Ng dksh limit up? hehe
10/11/2020 8:50 AM
investorking2020 Guys, better cash in all gains soonest. DKSH will not benefit much from the vaccine story. They do not have any concrete deal assigned, margins will be questionable, they are neither the main distributor for J&J, nor AZ, nor Pfizer. And anyways, they do not have the infrastructure to distribute all the vaccines. Reality is, they suffer from lockdown and will not win from vaccine. All those that buy their share because of that are either gambling or clueless or both.
10/11/2020 9:24 AM
GorengHealthcare Took profit DKSH. Divert the funds to glove
10/11/2020 9:29 AM
investorking2020 Well done! Smart move.
10/11/2020 9:32 AM
cbkia4896 Those here might believe that dksh might be in an attempt to negotiate for an asia region for vaccine contract from the states. Let's hope it happens soon
10/11/2020 11:02 AM
investorking2020 You must be kidding! Do you seriously believe that Asia's Governments appoint DKSH to negotiate on their behalf?! You may want to have a look whom is talking to whom about vaccines. In that game a peanuts company like DKSH is maybe asked to provide a fridge to store products for a while, but that is about it. But they will surely make a lot of money with it. Good luck if that is how you make investment decisions.
10/11/2020 2:10 PM
cbkia4896 Yeah, I'm just giving my opinion on what COULD happen. Maybe not Malaysia...
https://www.nationthailand.com/business/30204189
I'm just parking some extras I have here today at 3.09~3.12 but just take it with a pinch of salt
10/11/2020 5:07 PM
bclim_83 DKSH itself is a trustable brand for many MNCs in whom they can rely on distributing their products and avoid credit loss from trade receivables by appointing DKSH as their sole distributor. The advantage of DKSH is its presence in over 60 countries in europe and esp. in Asia. It has also established significant network and logistic facilities in Msia for over 90 years. I dont think government can give vaccine to all of us. At the end, some ppl will pay for vaccine themselves from private healthcare facilities. There will be also various brands of vaccine from China and famous pharma companies like pfizer with proven track record. DKSH may or may not become the distributor for vaccine. Regardless of the vaccine, the company has been growing at CAGR of ard 20% for the past 10 years based on Dynaquest. Last yr, it only bought AURIC which could be the next phase of growth for the company. So investing in DKSH is not solely depend on vaccine
10/11/2020 6:42 PM
bclim_83 https://www.klsescreener.com/v2/news/view/715497
10/11/2020 6:48 PM
cbkia4896 Hmmm im just here because I'm partially betting on dksh become a distributor for Pfizer's. If financial performance is good. Why not stay here instead of bintai or solution
10/11/2020 7:44 PM
cbkia4896 Hmmmm
Consistent profit even in MCO
Potential vaccine partnership
Cold chain logistic technology
Me like
... And here I thought it only have relation with j&j.... Mhmmmm me and dksh gonna be best buds
10/11/2020 8:32 PM
cbkia4896 lai liao la peeps, strap on your seatbelt
https://www.dksh.com/global-en/insights/opportunities-and-challenges-to-bringing-a-covid-19-vaccine-to-asian-citizens
dksh make statement of -70c cold chain capabilities.
16/11/2020 12:25 PM
Orlando cbkia is tis true for DKSH Malaysia too?
16/11/2020 2:10 PM
cbkia4896 Hi Orlando, dksh Msia is still closely knitted to dksh global. So both sides will benefits in terms of a covid 19 vaccine contract. Pretty sure there was a research TP of more than 3.50 just on speculations of contracts and it's regional growth based on its Qr performance. Im still holding mine atm, but if anyone would sell below rm3 I'm more than happy to collect more
16/11/2020 2:22 PM
Orlando Ok tqvm I wil hv my eyes on dksh
16/11/2020 2:27 PM
investorking2020 Suggest you wait for vaccine partnership to be announced. Even then profitability would be questionable. Almost definitely DKSH has no ability to run a large-scale cold chain project like this with existing facility. Only knowledge alone will not be sufficient. If COVID would be such great deal for DKSH, why then DKSH parent company share price not moving? You think shareholders do not understand? Only Malaysia shareholders do? This is baseless local speculation where a few shares traded already move the price. Good luck!
16/11/2020 3:30 PM
cbkia4896 haiya investor king, just park bit money here la, if up up lo, if down then wait lo, dksh good fundamental, so far this year qoq got profit,
https://klse.i3investor.com/blogs/savemalaysia/2020-11-16-story-h1536438016-Who_will_be_the_preferred_COVID_19_vaccine_logistics_provider.jsp
@savemalaysia also highlighted the possibilities here, so must be bit optimistic can? @investorking2020 why u make account just to comment? u want collect before fly is it? tbh i also want more at 2.8~2.9 but i was betting on it reaching 2.5~~~ too bad too bad tsk tsk tsk...
16/11/2020 9:28 PM
cbkia4896 first roadblock: 3.3
second roadblock 3.7
after 2nd roadblock sky is the limit
can one laaaaa if kennot then go back to solution or bintai or kanger looooo
16/11/2020 9:31 PM
cbkia4896 First roadblock cleared. Congrats
17/11/2020 12:25 PM
QTG7623 Bila keluar QR?
17/11/2020 12:44 PM
cbkia4896 where is investorking 2020 now? go back to hide ah?
17/11/2020 10:25 PM
cbkia4896 Dksh Swiss also rose 10 percent this week. For a rm300 per share counter.... I'm calling that something gonna happen to dksh soon. Maybe an official agreement with one of the big pharma giants
18/11/2020 1:42 AM
VenFx PROPOSED ISSUANCE OF UP TO 705,176,354 FREE WARRANTS IN [ GD EXPRESS CARRIER BHD ] ("GDEX") ("WARRANTS C") ON THE BASIS OF ONE (1) WARRANT C FOR EVERY EIGHT (8) EXISTING ORDINARY SHARES IN GDEX HELD ON AN ENTITLEMENT DATE TO BE DETERMINED AND ANNOUNCED LATER


SO MANY GOODIES IN THERE !
exercise price warrants assuming to be at 0.420
Go calculate for the fv price of Gdex.

EGM on (03.12.2020) to be approved , I guess.


Ahh haa , there is a tax relief link shared at Gdex s thread.
Pls do read there.
18/11/2020 12:12 PM
investorking2020 cbkia, no need for hiding. I remain: You guys will (a) be surprised how little DKSH will be involved in distribution of COVID vaccines at the end. Wait and find out. This may give you a first idea:

https://www.theedgemarkets.com/article/kanger-ropes-more-collaborators-help-distribute-covid19-vaccines

And (b) the rest of the business will surely be impacted by COVID restrictions and not do well. For that just wait until end of November when Q3 report is out.

Totally accept that the baseless speculation surrounding the vaccine offer a lot of opportunities with this stock, but just keep in mind that company fundaments are bad. If a company promoting e-commerce as main pillar has to fire the CIO, not a good sign. Something is going wrong at DKSH.
18/11/2020 12:52 PM
cbkia4896 okok, i exit first.. tiong nam and tasco going down faster than i thought, dragging my dksh along.
Will kutip balik if Qr cantik, gonna go back to gloves for a while. Ruberex looks yummy
18/11/2020 3:45 PM
cbkia4896 ok u win this round investorking, malaysia officially buying vaccine only for PRC
18/11/2020 4:46 PM
apple168 Saya mewakili kerajaan Malaysia menandatangani perjanjian kerjasama antara kerajaan China yang akan membolehkan Malaysia mendapat akses kepada vaksin COVID-19 daripada negara China apabila ia terbukti selamat dan berkesan.

Perjanjian ini juga akan menyaksikan diplomasi sains yang lebit erat antara kedua-dua buah negara bagi tujuan penyelidikan dan pembangunan vaksin menerusi entiti kerajaan mahupun swasta pada masa hadapan.

—> from khairy jamaluddin
18/11/2020 8:39 PM
apple168 No hope to get Pfizer vaccine to Malaysia
18/11/2020 8:40 PM
NPRA1985 Kanger International Bhd has roped in Zuellig Pharma Sdn Bhd and K-Star Sport Ltd to collaborate on the distribution of Covid-19 vaccines in Malaysia.

The vaccine and other products are developed by state-owned China National Pharmaceutical Group Corp (Sinopharm).

https://www.theedgemarkets.com/article/kanger-ropes-more-collaborators-help-distribute-covid19-vaccines
18/11/2020 11:56 PM
NPRA1985 Pfizer and BioNTech say final analysis shows coronavirus vaccine is 95% effective with no safety concerns

https://edition.cnn.com/2020/11/18/health/pfizer-coronavirus-vaccine-safety/index.html
18/11/2020 11:56 PM
bclim_83 There is no way that our government will provide vaccine to all Malaysians. Just like other medicines, there will be certain medicines only available in private sector. There will be people will need to buy the vaccine on their own from private sector. DKSH mostly supplies to private sector and some to government sector as they usually supplies original drugs from MNC such as pfizer, Johnson & Johnson.... they still stand a chance to distribute the vaccine. Pls get to know more about pharma supply in Malaysia. Does not mean that msia sign vaccine agreement with china, other companies' vaccine will not enter msia. The government would be happy if those who are not high risk will get vaccinated using their own money. The vaccine purchased by government will only 1st be given to high risk group, 1st given to only 10% of population. To achieve herd immunity, it will need to vaccinate at least 70% of the population. No way the government will achieve this alone without the help from ppl and private sector
19/11/2020 8:29 AM
bclim_83 Similarly like the covid test kits. Msia bought the kits from certain countries for MOH use. But, there are many private hospitals and clinics also purchase the test kits from other companies or countries as long as the kits fulfill MOH criteria. The same goes to vaccine. Some low risk ppl in our countries may opted to buy the vaccine from MNC like pfizer with proven track record and openly published data. So far China or russian companies have not provided the data of their vaccine
19/11/2020 8:38 AM
investorking2020 bclim_83, you are certainly right with your assumptions. However, the problem for DKSH will be that they are not the current distributor for Pfizer, J&J or AstraZeneca. All of these manufacturers have chosen to work exclusively with a competitor. I strongly recommend you to investigate yourself and recalibrate your above statement. Your current understanding of DKSH's principals is simply incorrect. You will find that the chance of DKSH taking a significant share in the distribution of their vaccines is fairly slim. Hence, pricing that into the share price is without substance but only speculation on basis of false rumors. Your money, not mine.
19/11/2020 8:58 AM
bclim_83 Like i said before, investing in DKSH does not solely depend on vaccine. This company has been growing with CAGR of ard 20% for the past 10 years without the vaccine. Almost every household is using the products they distribute or using their in house brands. They may or may not distribute the vaccine. If they does, it ia a plus. By the way, they are distributor of pfizer, J&J products in Malaysia and also over 60 countries worldwide. U may check in their website or analyst presentation
19/11/2020 9:49 AM
investorking2020 bclim_83, only because they mention names in their presentation does not automatically mean that they are their main distributor. They may provide some services to the mentioned companies, but they are not their exclusive distributor. Do not trust marketing material only. If you do not believe, you may want to ask DKSH explicitly.

For the rest of your argument, I agree. But under current circumstances the other business does not justify any hype or surge in share price.
19/11/2020 10:57 AM
smallboybuyshares Stupid if u dun sell
19/11/2020 12:48 PM
cbkia4896 sell sell sell
buy solution
buy LKL
buy Mahsing
buy Bintai
buy Kanger
Sell till below rm3 then i kutip back
19/11/2020 4:27 PM
007007 Nobody said that DKSH already confirmed won the distribution rights. No one has been confirmed. Share price will go up based on possibilities......same applies to Tnlogis, Tasco, Dpharma, etc. Share price always go up in anticipation.
20/11/2020 1:35 PM
007007 Also......there will be multiple types of vaccines, not just confined to Pfizer. There will be enough business for everyone to share. No single company can monopolise the distribution business.
20/11/2020 1:53 PM
007007 DKSH, Zuellig, Tasco, Tnlogis, Dpharma, Pharma, etc....all will benefit to some extent.
20/11/2020 1:55 PM
007007 Khairy Jamaludin "already informed the Dewan Rakyat that the government was in direct contacts with eight vaccine producers and two via the Covax plan.".......Star newspaper today.
20/11/2020 1:59 PM
007007 The real issue is whether the company is qualified to handle the vaccines.
20/11/2020 2:01 PM
NPRA1985 EU says 2 Covid-19 vaccines could be approved this year

https://www.freemalaysiatoday.com/category/world/2020/11/20/eu-says-2-covid-19-vaccines-could-be-approved-this-year/
20/11/2020 2:44 PM
NPRA1985 Regardless, the budget for Covid-19 Vaccines is secure. Hence, nothing to worry for Covid-19 vaccine related counters.

---------------

The MPs told Malaysiakini that in the event Budget 2021 was not passed, ARTICLE 102 of the FEDERAL CONSTITUTION could be invoked to table a separate bill to authorise essential spending.

Essential spending could include civil servant emoluments and HEALTHCARE EXPENSES needed to battle the Covid-19 pandemic.

https://www.malaysiakini.com/news/551768
22/11/2020 11:59 PM
sapurakencana Bclim : see the DKSH flying colour result without Vaccine, Please focus on their current business model,otherwise you will loss this opportunity.I invest in this counter due to it solid distribution & marketing business. Please read their report carefully.
25/11/2020 6:37 PM